SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (825)6/16/2004 5:03:42 PM
From: Icebrg  Read Replies (2) of 2240
 
France's IDM Delays IPO Because Of Adverse Market Conditions

PARIS -(Dow Jones)- French drug maker IDM said Wednesday it has decided to postpone its planned initial public offering on the small-cap segment of the Paris bourse, initially scheduled Thursday, because of adverse market conditions.

IDM has six compounds under development, including Mepact, a cancer drug for the treatment of osteosarcoma.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News